Literature DB >> 26431583

Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.

Han Song1, Young Yoo2, Junghyun Hwang1, Yun-Cheol Na3, Heenam Stanley Kim4.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a serious global epidemic associated with a modern lifestyle.
OBJECTIVE: Although aberrant interactions between gut microbes and the intestinal immune system have been implicated in this skin disease, the nature of the microbiome dysfunction underlying the disease remains unclear.
METHODS: The gut microbiome from 132 subjects, including 90 patients with AD, was analyzed by using 16S rRNA gene and metagenome sequence analyses. Reference genomes from the Human Microbiome Project and the KEGG Orthology database were used for metagenome analyses. Short-chain fatty acids in fecal samples were compared by using gas chromatographic-mass spectrometric analyses.
RESULTS: We show that enrichment of a subspecies of the major gut species Faecalibacterium prausnitzii is strongly associated with AD. In addition, the AD microbiome was enriched in genes encoding the use of various nutrients that could be released from damaged gut epithelium, reflecting a bloom of auxotrophic bacteria. Fecal samples from patients with AD showed decreased levels of butyrate and propionate, which have anti-inflammatory effects. This is likely a consequence of an intraspecies compositional change in F prausnitzii that reduces the number of high butyrate and propionate producers, including those related to the strain A2-165, a lack of which has been implicated in patients with Crohn disease.
CONCLUSIONS: The data suggest that feedback interactions between dysbiosis in F prausnitzii and dysregulation of gut epithelial inflammation might underlie the chronic progression of AD by resulting in impairment of the gut epithelial barrier, which ultimately leads to aberrant TH2-type immune responses to allergens in the skin.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Faecalibacterium prausnitzii; dysbiosis; gut microbiota; microbiome

Mesh:

Substances:

Year:  2015        PMID: 26431583     DOI: 10.1016/j.jaci.2015.08.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  101 in total

1.  Next-generation probiotics: the spectrum from probiotics to live biotherapeutics.

Authors:  Paul W O'Toole; Julian R Marchesi; Colin Hill
Journal:  Nat Microbiol       Date:  2017-04-25       Impact factor: 17.745

Review 2.  Microbiome and its impact on gastrointestinal atopy.

Authors:  A B Muir; A J Benitez; K Dods; J M Spergel; S A Fillon
Journal:  Allergy       Date:  2016-06-23       Impact factor: 13.146

Review 3.  Microbial interactions in the atopic march.

Authors:  B Nibbering; N D J Ubags
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

4.  Dysbiosis of Inferior Turbinate Microbiota Is Associated with High Total IgE Levels in Patients with Allergic Rhinitis.

Authors:  Dong-Wook Hyun; Hyun Jin Min; Min-Soo Kim; Tae Woong Whon; Na-Ri Shin; Pil Soo Kim; Hyun Sik Kim; June Young Lee; Woorim Kang; Augustine M K Choi; Joo-Heon Yoon; Jin-Woo Bae
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

5.  Gut microbiota: Microbiota and behaviour: visiting the sins of the mother.

Authors:  Paul Forsythe; John Bienenstock
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-27       Impact factor: 46.802

Review 6.  Signals from the gut microbiota to distant organs in physiology and disease.

Authors:  Bjoern O Schroeder; Fredrik Bäckhed
Journal:  Nat Med       Date:  2016-10-06       Impact factor: 53.440

7.  Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.

Authors:  Eric Climent; Juan Francisco Martinez-Blanch; Laura Llobregat; Beatriz Ruzafa-Costas; Miguel Ángel Carrión-Gutiérrez; Ana Ramírez-Boscá; David Prieto-Merino; Salvador Genovés; Francisco M Codoñer; Daniel Ramón; Empar Chenoll; Vicente Navarro-López
Journal:  Microorganisms       Date:  2021-04-15

Review 8.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

9.  Specific gut microbiome signature predicts the early-stage lung cancer.

Authors:  Yajuan Zheng; Zhaoyuan Fang; Yun Xue; Jian Zhang; Junjie Zhu; Renyuan Gao; Shun Yao; Yi Ye; Shihui Wang; Changdong Lin; Shiyang Chen; Hsinyi Huang; Liang Hu; Ge-Ning Jiang; Huanlong Qin; Peng Zhang; Jianfeng Chen; Hongbin Ji
Journal:  Gut Microbes       Date:  2020-04-02

10.  Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.

Authors:  Vicente Navarro-López; Ana Ramírez-Boscá; Daniel Ramón-Vidal; Beatriz Ruzafa-Costas; Salvador Genovés-Martínez; Empar Chenoll-Cuadros; Miguel Carrión-Gutiérrez; José Horga de la Parte; David Prieto-Merino; Francisco M Codoñer-Cortés
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.